# China Oncology Information Systems Market

> China Oncology Information Systems Market Research Report By Product Type (Software, Professional Services), By Application (Medical Oncology, Radiation Oncology, Surgical Oncology) and By End User (Hospitals & Oncology Clinics, Government Institutes, Research Centers) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.62%
- **2024:** $ 347.76 Million
- **2025:** $ 374.26 Million
- **2035:** $ 780 Million
- **Key Players:** Varian Medical Systems (US), Elekta AB (SE), Philips Healthcare (NL), Siemens Healthineers (DE), GE Healthcare (US), Cerner Corporation (US), McKesson Corporation (US), Allscripts Healthcare Solutions (US)

**Report ID:** MRFR/Pharma/48656-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/china-oncology-information-systems-market-50413

---

## Market Summary

## **China Oncology Information Systems Market Overview**

As per MRFR analysis, the China Oncology Information Systems Market Size was estimated at 352.2 (USD Million) in 2024.The China Oncology Information Systems Market Industry is expected to grow from 462(USD Million) in 2025 to 1,109 (USD Million) by 2035. The China Oncology Information Systems Market CAGR (growth rate) is expected to be around 8.286% during the forecast period (2025 - 2035)

**Key China Oncology Information Systems Market Trends Highlighted**

In China, the Oncology Information Systems market is experiencing significant growth driven by an increasing incidence of cancer and a growing aging population. The Chinese government has been actively promoting healthcare reforms, focusing on enhancing cancer treatment infrastructure, which serves as a strong market driver. Recent legislation has reinforced the need for integrated healthcare services, emphasizing the importance of capturing patient data and streamlining treatment protocols. This has led to a surge in demand for advanced oncology information systems that can provide real-time analytics and personalized treatment plans. 

Additionally, technological advancements, such as the integration of artificial intelligence and machine learning into oncology information systems, are gaining traction.These technologies help in predictive analytics, improving decision-making in treatment processes. This trend is bolstered by China's commitment to becoming a leader in digital health, evident through initiatives aimed at developing a robust health technology sector. Furthermore, there is a growing opportunity for local vendors to innovate and tailor their services to meet the unique demands of Chinese healthcare professionals and institutions. 

Moreover, collaborations between private companies and public healthcare providers are becoming increasingly common, highlighting the trend of partnerships to leverage expertise in developing comprehensive oncology care systems.The focus is on creating platforms that are not only efficient but also compliant with Chinese regulations. As awareness of cancer care and management progresses, the necessity for effective oncology information systems in China is expected to keep rising, opening further avenues to be explored in enhancing patient outcomes and operational efficiencies in healthcare settings.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**China Oncology Information Systems Market Drivers**

**Rising Incidence of Cancer in China**

The increasing incidence of cancer in China is a significant driver for the China Oncology Information Systems Market industry. According to the National Cancer Center of China, the number of new cancer cases in 2020 was approximately 4.57 million, which translates to an annual increase of around 15% over the past decade. This alarming trend is expected to fuel the demand for advanced oncology information systems, enabling better patient management, treatment planning, and overall care coordination among healthcare providers.The diagnostic and treatment protocols made by prominent institutions, like the Chinese Society of Clinical Oncology are continuously being advanced.

This, in turn, raises the need for highly developed information systems to assist the medical practitioners in efficiently attending to the increasing patient population.

**Government Initiatives and Investments in Healthcare**

The Chinese government is heavily investing in the healthcare sector, particularly in oncology care. The 'Healthy China 2030' initiative aims to increase healthcare accessibility and quality, focusing on cancer prevention and control. Reports from the Ministry of Health indicate that funding for cancer research and healthcare infrastructure has grown by approximately 10% annually, driving demand for oncology information systems. Organizations like the Chinese Medical Association are also involved in promoting this initiative, advocating for improved healthcare technologies that align with national policy goals, thereby enhancing the market potential for oncology information systems.

**Technological Advancements in Healthcare**

Technological advancements in healthcare are rapidly transforming the China Oncology Information Systems Market industry. Innovations in artificial intelligence and machine learning are enabling the development of more efficient diagnostic and treatment planning tools. For instance, the National Health Commission has reported that about 30% of Chinese hospitals are now utilizing advanced data analytics in oncology, leading to improved treatment outcomes.Companies like WuXi AppTec and 3D Medicines are leading the way in developing integrated oncology information systems that leverage these technologies, which enhances the overall market potential in China.

**Growing Demand for Personalized Medicine**

The shift towards personalized medicine is significantly contributing to the growth of the China Oncology Information Systems Market industry. With increasing awareness and research into genetic profiling and tailored treatment plans, there is a growing need for robust data management systems to handle complex patient information. According to a report from the Chinese Academy of Medical Sciences, approximately 40% of oncologists in China are now incorporating personalized medicine into their treatment strategies.This demand for customization drives the necessity for oncology information systems that can support data integration and analysis, fostering growth opportunities within the market.

**China Oncology Information Systems Market Segment Insights**

**Oncology Information Systems Market Product Type Insights**

The China Oncology Information Systems Market is experiencing notable growth driven by the increasing demand for innovative solutions in cancer care and management. Within the Product Type segment, the primary offerings can be categorized into Software and Professional Services, both of which play a critical role in enhancing oncology practices across the region. Software solutions encompass a range of applications designed to streamline and optimize workflows in oncology departments, including Electronic Health Records, treatment planning, and patient management systems.

As healthcare providers in China continue to adopt digital transformation strategies, the demand for sophisticated oncology software solutions has seen significant traction, allowing for improved patient outcomes and operational efficiencies.

On the other hand, Professional Services, which include consultation, implementation, support, and training, are essential for facilitating the successful adoption and utilization of oncology information systems. The diverse nature of healthcare settings in China requires tailored professional services to meet specific organizational needs, ensuring that oncology departments are equipped to deliver high-quality care. The integration of technology with professional expertise further enhances the effectiveness of these systems, as clinicians can leverage insights derived from robust data analytics to inform treatment decisions and improve patient care pathways.

Overall, this Product Type segment serves as a foundation for bolstering the capabilities of healthcare providers throughout China, driving the ongoing digital transformation within the oncology landscape. As the country grapples with the rising incidence of cancer, these offerings are pivotal in responding to the demand for more efficient, data-driven solutions that support comprehensive cancer management and improve care delivery across the healthcare continuum. The continuous innovation in software and the provision of professional services will likely support the market growth and propel advancements in treating oncology patients, directly responding to the evolving healthcare needs within the Chinese population.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Oncology Information Systems Market Application Insights**

The Application segment of the China Oncology Information Systems Market is crucial for addressing the unique needs of cancer treatment and management across various specialties. Medical Oncology, which involves the use of medication to treat cancer, plays a vital role in improving patient outcomes through personalized treatment plans. It focuses on drug therapies and has seen significant advancements due to ongoing Research and Development initiatives in China, leading to enhanced treatment efficacy. Radiation Oncology is another key area that utilizes advanced technology for precise targeting of tumors, contributing to better survival rates and minimized side effects for patients.

This field is essential for integrating treatment protocols and patient data management. Lastly, Surgical Oncology emphasizes the importance of operative interventions in cancer care, emphasizing the need for comprehensive data systems to facilitate surgical planning and patient history tracking. Collectively, these aspects of the Application segment highlight the multidimensional approach required for effective oncology information systems, reflecting the growing demand for integrated healthcare solutions in China's rapidly evolving oncology landscape.The overall growth in this sector is driven by increasing cancer prevalence and a rising emphasis on data-driven personalized treatment protocols.

**Oncology Information Systems Market End User Insights**

The End User segment of the China Oncology Information Systems Market plays a critical role in enhancing patient care and treatment outcomes. This segment is primarily dominated by Hospitals and Oncology Clinics, which are increasingly adopting advanced information systems to streamline patient management, improve data accuracy, and foster better interdisciplinary collaboration. Government Institutes are also significant as they drive regulatory standards and funding for oncology care, aiming to improve public health outcomes. Research Centers contribute to this market by utilizing these systems to support ongoing clinical trials and innovative treatments, thus facilitating the advancement of cancer research and therapy development.

The growing prevalence of cancer in China emphasizes the importance of efficient oncology information systems across these various End Users, resulting in increased focus on integrating technologies that can enhance operational efficiency and patient satisfaction while addressing the unique challenges presented by the healthcare landscape in the region. As the healthcare infrastructure evolves, these segments will continue to leverage technology, ensuring optimal delivery of oncology care and positioning themselves for future growth within the market.

**China Oncology Information Systems Market Key Players and Competitive Insights**

The China Oncology Information Systems Market is characterized by a dynamic competitive landscape that reflects the growing demand for cancer care and management solutions across the nation. With an increasing prevalence of cancer and a push towards more efficient healthcare systems, various players are entering the market with innovative solutions that enhance diagnostic precision, treatment planning, and patient management. The integration of advanced technologies, including artificial intelligence and data analytics, is transforming traditional oncology practices and enabling healthcare providers to tailor treatments to individual patient needs. 

The competitive scenario is defined by collaboration among industry leaders, healthcare institutions, and technology innovators, aiming to deliver comprehensive oncology information systems that streamline operations and improve patient outcomes. This market is underscored by various strategic initiatives, including partnerships and mergers, as companies seek to bolster their service capabilities and expand their reach.UnitedHealth Group demonstrates a significant presence in the China Oncology Information Systems Market through its robust portfolio of healthcare services and technology-driven solutions. Its strengths lie in its deep understanding of healthcare frameworks and the integration of clinical data systems aimed at enhancing oncology patient care. 

The company leverages its vast data analytics capabilities to empower oncology specialists with actionable insights, allowing for better decision-making and improved patient treatment plans. UnitedHealth Group's commitment to innovation in technology and patient-centric approaches positions it as a strong competitor in this market. Its operational efficiencies, extensive networks, and healthcare management systems support oncologists and healthcare institutions in delivering quality care, ensuring that patients receive timely and effective treatments.Bayer plays a vital role in the China Oncology Information Systems Market, focusing on both therapeutic innovation and digital health solutions. 

The company offers key products and services that include advanced oncology treatments and integrated information systems to optimize cancer care delivery. Bayer's strengths reside in its established reputation for high-quality pharmaceutical products and its strategic partnerships with healthcare providers, which enhance its market presence in oncology. The company has been active in pursuing mergers and acquisitions to strengthen its competencies in digital health, particularly in the oncology domain. By combining its extensive research and development capabilities with digital health innovations, Bayer aims to provide healthcare professionals with the tools necessary for effective cancer management.

The firm’s commitment to continuous improvement and contribution to healthcare ecosystems positions it as a prominent player in catering to the diverse needs of oncology care in China.

**Key Companies in the China Oncology Information Systems Market Include**

**China Oncology Information Systems Market Industry Developments**

Recent developments in the China Oncology Information Systems Market indicate a significant transformation, highlighted by strategic collaborations and technological advancements. Notably, UnitedHealth Group has engaged in partnerships aimed at improving digital health solutions for cancer care enhancing patient management processes. Bayer and Merck & Co. continue to expand their digital platforms to streamline oncology treatments, while Roche is focusing on integrating artificial intelligence into treatment planning and patient monitoring systems.

In terms of mergers and acquisitions, Bayer announced in June 2023 its acquisition of a Chinese biotech firm specializing in oncology data analytics, which is expected to amplify its influence in the Chinese market significantly. 

Additionally, Cerner Corporation has been enhancing its Oncology Information Systems platform to align with local healthcare regulations, boosting its market presence in China. The market valuation for key players like Novartis and Amgen is projected to rise, driven by increased investments in Research and Development and innovative treatment approaches. In the past couple of years, significant advancements were noted, including new regulatory frameworks introduced by China's National Medical Products Administration (NMPA) in early 2022, aiding quicker access to innovative cancer therapies and information systems.

**China Oncology Information Systems Market Segmentation Insights**

## Market Drivers

### Rising Cancer Incidence

The oncology information-systems market in China is experiencing growth due to the rising incidence of cancer. According to the National Cancer Center, cancer cases in China are projected to reach approximately 4.6 million by 2025. This alarming trend necessitates advanced information systems to manage patient data, treatment plans, and outcomes effectively. As healthcare providers seek to enhance their capabilities in oncology care, the demand for sophisticated information systems is likely to increase. The integration of these systems can facilitate better patient management and improve treatment efficacy, thereby driving the market forward. Furthermore, the increasing awareness of cancer screening and early detection is expected to contribute to the growth of the oncology information-systems market, as more patients seek timely interventions.

### Government Initiatives and Funding

Government initiatives aimed at improving cancer care in China are significantly impacting the oncology information-systems market. The Chinese government has allocated substantial funding to enhance healthcare infrastructure, including the development of advanced oncology information systems. For instance, the Healthy China 2030 initiative emphasizes the importance of cancer prevention and control, which includes investments in digital health technologies. This financial support is likely to encourage healthcare institutions to adopt innovative information systems that streamline operations and improve patient outcomes. Additionally, public-private partnerships are emerging, further bolstering the oncology information-systems market by fostering collaboration between technology providers and healthcare organizations.

### Technological Advancements in Healthcare

Technological advancements are playing a crucial role in shaping the oncology information-systems market in China. Innovations such as big data analytics, machine learning, and telemedicine are being integrated into oncology information systems, enhancing their functionality and effectiveness. These technologies enable healthcare providers to analyze vast amounts of patient data, leading to more personalized treatment plans and improved patient outcomes. The market is likely to benefit from the increasing adoption of these technologies, as they facilitate better decision-making and operational efficiency. Moreover, the growing trend of remote patient monitoring is expected to further drive the demand for advanced oncology information systems, as healthcare providers seek to offer comprehensive care solutions.

### Increasing Demand for Patient-Centric Care

The shift towards patient-centric care is influencing the oncology information-systems market in China. Patients are increasingly seeking personalized treatment options and greater involvement in their healthcare decisions. This trend is prompting healthcare providers to adopt information systems that prioritize patient engagement and satisfaction. Oncology information systems that offer features such as patient portals, treatment tracking, and educational resources are becoming essential tools for providers. As a result, the market is likely to see a rise in demand for systems that enhance communication between patients and healthcare professionals, ultimately leading to improved treatment adherence and outcomes.

### Growing Focus on Data Security and Compliance

Data security and compliance are becoming paramount in the oncology information-systems market in China. With the increasing digitization of healthcare data, concerns regarding patient privacy and data breaches are on the rise. Regulatory bodies are implementing stricter guidelines to ensure the protection of sensitive health information. Consequently, healthcare organizations are compelled to invest in oncology information systems that prioritize data security and comply with regulations. This focus on security not only protects patient information but also enhances the credibility of healthcare providers. As a result, the oncology information-systems market is likely to expand as organizations seek to adopt secure and compliant solutions.

## Future Outlook

The [Oncology Information Systems Market](https://www.marketresearchfuture.com/reports/oncology-information-systems-market-7080) in China is projected to grow at a 7.62% CAGR from 2025 to 2035, driven by technological advancements and increasing cancer prevalence.

**New opportunities:**

- Integration of AI-driven analytics for personalized treatment plans.
- Development of cloud-based oncology data management solutions.
- Expansion of telehealth services for remote patient monitoring and consultations.

By 2035, the oncology information-systems market is expected to be robust and innovative.

## Segment Insights

### By Product and Service Type: Software (Largest) vs. Professional Services (Fastest-Growing)

The China oncology information-systems market is characterized by a significant distribution of market share between software and professional services. Software solutions continue to dominate the sector due to their ability to streamline processes and improve clinical decision-making. On the other hand, professional services occupy a smaller share but are essential for implementation and ongoing support, making them critical to the overall success of the systems.

Currently, professional services are emerging as the fastest-growing segment, driven by increasing demand for tailored solutions and expert consulting in cancer treatment planning and management. The shift towards personalized oncology care and the need for advanced analytics in treatment protocols are major drivers. Both segments are expected to evolve rapidly as healthcare providers seek to enhance patient outcomes and operational efficiency.

Software (Dominant) vs. Professional Services (Emerging)

Software solutions are the dominant force in the China oncology information-systems market, providing comprehensive platforms for data management, patient tracking, and treatment planning. These systems are designed to integrate various aspects of oncology care, making them invaluable for healthcare providers. In contrast, professional services, while emerging, play a pivotal role by offering specialized support and consulting that facilitate successful software implementation. The increasing complexity of oncology treatments necessitates the expertise provided by professional services, thereby positioning them as a critical complement to software offerings. This combination allows for improved operational effectiveness and better patient care outcomes.

### By Application: Medical Oncology (Largest) vs. Surgical Oncology (Fastest-Growing)

In the China oncology information-systems market, Medical Oncology holds the largest market share due to its wide application in cancer treatment and management. This segment encompasses a variety of therapeutic approaches, accounting for a significant proportion of the total market. Conversely, Surgical Oncology is rapidly emerging, fueled by advancements in surgical techniques and increased adoption of minimally invasive procedures, leading to notable growth in its market share.

The growth trends within the application segment are driven by several factors, including the rising incidence of cancer cases prompting higher investments in oncological therapies. Moreover, the shift towards personalized medicine and technological innovations in data management are positioning Radiation Oncology and Surgical Oncology as vital contributors to the sector's evolution. These drivers suggest a robust future outlook for both dominant and emerging segments within the market.

Medical Oncology (Dominant) vs. Surgical Oncology (Emerging)

Medical Oncology is characterized by tailored treatment plans that include chemotherapy, immunotherapy, and targeted therapy, making it a cornerstone of cancer treatment. The high adoption rates of these therapies are supported by strong clinical evidence and growing awareness among healthcare professionals and patients alike. In contrast, Surgical Oncology has seen significant advancements and is becoming increasingly sophisticated. With the introduction of robotic-assisted surgeries and enhanced imaging techniques, it is poised to expand rapidly. The integration of minimally invasive surgical methods is becoming popular, improving recovery times and patient outcomes, positioning Surgical Oncology as a key area of growth in the oncology information-systems landscape.

### By End-User: Hospitals & Oncology Clinics (Largest) vs. Research Centers (Fastest-Growing)

The China oncology information-systems market exhibits a diverse range of end-users, with Hospitals & Oncology Clinics securing the largest market share. This segment encompasses a variety of healthcare facilities that are pivotal in providing specialized cancer treatment and ongoing patient management. In contrast, Research Centers are emerging strongly due to their increasing focus on cancer research and technological advancements, capturing a growing portion of the market as they innovate and improve care methodologies.

Growth trends indicate that Hospitals & Oncology Clinics will continue to thrive as they adapt to the rising demand for advanced oncology solutions. Conversely, Research Centers are becoming the fastest-growing segment, driven by increased investments in cancer research and the integration of cutting-edge technologies, such as artificial intelligence and data analytics, into existing systems. These factors are creating a dynamic landscape within the China oncology information-systems market.

Hospitals & Oncology Clinics (Dominant) vs. Research Centers (Emerging)

Hospitals & Oncology Clinics are positioned as the dominant players in the China oncology information-systems market, characterized by their expansive networks and comprehensive treatment options. They serve a significant patient base, leveraging advanced oncology management systems to enhance treatment outcomes. On the other hand, Research Centers are viewed as an emerging force, reflecting a growing trend towards innovation and research. These centers are essential for developing new therapies and integrating technological advancements into treatment protocols. Their commitment to research and collaboration with healthcare providers enhances their market position, enabling them to contribute substantially to the evolution of oncology treatments in the region.

## Competitive Benchmarking

The oncology information-systems market in China is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for efficient cancer care solutions. Key players such as Varian Medical Systems (US), Elekta AB (SE), and Siemens Healthineers (DE) are actively shaping the market through strategic initiatives focused on innovation and regional expansion. Varian Medical Systems (US) emphasizes its commitment to enhancing treatment precision through advanced software solutions, while Elekta AB (SE) is leveraging partnerships to expand its product offerings and improve patient outcomes. Siemens Healthineers (DE) is also investing in digital transformation, aiming to integrate AI capabilities into its oncology systems, thereby enhancing operational efficiency and patient care.The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to better serve the Chinese market. The competitive structure of the oncology information-systems market appears moderately fragmented, with several key players exerting influence. This fragmentation allows for a diverse range of solutions, catering to various healthcare providers and patient needs, while also fostering innovation through competition.

In August  Varian Medical Systems (US) announced a strategic partnership with a leading Chinese healthcare provider to develop tailored oncology solutions. This collaboration is expected to enhance access to advanced treatment technologies in underserved regions, thereby expanding Varian's market presence and reinforcing its commitment to improving cancer care in China. The strategic importance of this partnership lies in its potential to address local healthcare challenges while positioning Varian as a leader in the region.

In September  Elekta AB (SE) launched a new cloud-based oncology information system designed to streamline data management and improve clinical workflows. This innovative solution is anticipated to enhance collaboration among healthcare professionals and facilitate better patient management. The launch signifies Elekta's focus on digitalization and its intent to remain competitive in a rapidly evolving market.

In October  Siemens Healthineers (DE) unveiled a new AI-driven analytics platform aimed at optimizing treatment planning and patient outcomes. This platform is expected to provide oncologists with actionable insights, thereby improving decision-making processes. The introduction of this technology underscores Siemens' commitment to integrating AI into its offerings, which may significantly enhance its competitive edge in the oncology information-systems market.

As of November  current trends in the oncology information-systems market include a strong emphasis on digitalization, sustainability, and AI integration. Strategic alliances among key players are increasingly shaping the competitive landscape, fostering innovation and collaboration. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability. Companies that successfully navigate these trends are likely to secure a more prominent position in the market.

## Recent News & Developments

Recent developments in the China Oncology Information Systems Market indicate a significant transformation, highlighted by strategic collaborations and technological advancements. Notably, UnitedHealth Group has engaged in partnerships aimed at improving digital health solutions for cancer care enhancing patient management processes. Bayer and Merck & Co. continue to expand their digital platforms to streamline oncology treatments, while Roche is focusing on integrating artificial intelligence into treatment planning and patient monitoring systems.

In terms of mergers and acquisitions, Bayer announced in June 2023 its acquisition of a Chinese biotech firm specializing in oncology data analytics, which is expected to amplify its influence in the Chinese market significantly. 

Additionally, Cerner Corporation has been enhancing its Oncology Information Systems platform to align with local healthcare regulations, boosting its market presence in China. The market valuation for key players like Novartis and Amgen is projected to rise, driven by increased investments in Research and Development and innovative treatment approaches. In the past couple of years, significant advancements were noted, including new regulatory frameworks introduced by China's National Medical Products Administration (NMPA) in early 2022, aiding quicker access to innovative cancer therapies and information systems.

## Report Scope

| MARKET SIZE 2024 | 347.76(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 374.26(USD Million) |
| MARKET SIZE 2035 | 780.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.62% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Varian Medical Systems (US), Elekta AB (SE), Philips Healthcare (NL), Siemens Healthineers (DE), GE Healthcare (US), Cerner Corporation (US), McKesson Corporation (US), Allscripts Healthcare Solutions (US) |
| Segments Covered | Product and Service Type, Application, End-User |
| Key Market Opportunities | Integration of artificial intelligence in oncology information-systems enhances patient management and treatment personalization. |
| Key Market Dynamics | Rapid technological advancements and regulatory changes drive growth in the oncology information-systems market. |
| Countries Covered | China |

## Frequently Asked Questions

**Q: What was the overall market valuation of the oncology information-systems market in 2024?**
A: The overall market valuation was $347.76 Million in 2024.

**Q: What is the projected market valuation for the oncology information-systems market by 2035?**
A: The projected valuation for 2035 is $780.0 Million.

**Q: What is the expected CAGR for the oncology information-systems market during the forecast period 2025 - 2035?**
A: The expected CAGR during the forecast period 2025 - 2035 is 7.62%.

**Q: Which segments contributed to the oncology information-systems market in 2024?**
A: In 2024, the segments included Software at $200.0 Million and Professional Services at $147.76 Million.

**Q: What are the key applications within the oncology information-systems market?**
A: Key applications include Medical Oncology at $104.0 Million, Radiation Oncology at $120.0 Million, and Surgical Oncology at $123.76 Million.

**Q: Who are the leading players in the oncology information-systems market?**
A: Key players include Varian Medical Systems, Elekta AB, Philips Healthcare, Siemens Healthineers, GE Healthcare, Cerner Corporation, McKesson Corporation, and Allscripts Healthcare Solutions.

**Q: What is the market size for hospitals and oncology clinics in 2024?**
A: The market size for hospitals and oncology clinics was $150.0 Million in 2024.

**Q: How much did government institutes contribute to the oncology information-systems market in 2024?**
A: Government institutes contributed $80.0 Million to the oncology information-systems market in 2024.

**Q: What is the projected growth for surgical oncology applications by 2035?**
A: Surgical Oncology applications are projected to grow to $260.0 Million by 2035.

**Q: What is the expected market size for research centers in 2035?**
A: The expected market size for research centers is $250.0 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-oncology-information-systems-market-50413*